7 April 2016Americas

DLA Piper adds partner and chair of FDA group

Law firm DLA Piper has hired James Czaban as a partner in the firm’s government affairs practice and chair of the firm’s US Food and Drug Administration group in Washington, DC.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

article

Why you shouldn’t overlook Canadian IP litigation

2 October 2017 Canada has a robust and reliable framework for resolving IP disputes, and it shouldn’t be ignored by litigants, say Ron Dimock, Sangeetha Punniyamoorthy and Nikolas Purcell of DLA Piper.

FDA clears orphan drug backlog

14 September 2017 The Food and Drugs Administration has cleared the backlog of orphan drug designation requests, one month early.

DLA Piper recruits life sciences lawyer for Silicon Valley

29 July 2014 DLA Piper has appointed life sciences lawyer Shane Albright to its corporate and finance practice.

More on this story

article

Why you shouldn’t overlook Canadian IP litigation

2 October 2017 Canada has a robust and reliable framework for resolving IP disputes, and it shouldn’t be ignored by litigants, say Ron Dimock, Sangeetha Punniyamoorthy and Nikolas Purcell of DLA Piper.

FDA clears orphan drug backlog

14 September 2017 The Food and Drugs Administration has cleared the backlog of orphan drug designation requests, one month early.

DLA Piper recruits life sciences lawyer for Silicon Valley

29 July 2014 DLA Piper has appointed life sciences lawyer Shane Albright to its corporate and finance practice.

More on this story

article

Why you shouldn’t overlook Canadian IP litigation

2 October 2017 Canada has a robust and reliable framework for resolving IP disputes, and it shouldn’t be ignored by litigants, say Ron Dimock, Sangeetha Punniyamoorthy and Nikolas Purcell of DLA Piper.

FDA clears orphan drug backlog

14 September 2017 The Food and Drugs Administration has cleared the backlog of orphan drug designation requests, one month early.

DLA Piper recruits life sciences lawyer for Silicon Valley

29 July 2014 DLA Piper has appointed life sciences lawyer Shane Albright to its corporate and finance practice.

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’

BMS unit loses cell therapy patent at European Patent Office

Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market

Lord Justice Birss to become chancellor of the High Court

Bankruptcy judge approves $305m sale of genetics testing company

Sanofi successfully challenges rare disease patent in Europe

Bayer appoints new head of IP

WATCH: Policy direction—where are we now?